Global Active Pharmaceuticals Ingredients Market 2019-2026
|醫藥品有效成分 (API)的全球市場 Global Active Pharmaceuticals Ingredients Market 2019-2026|
|出版日期: 按訂單生產||內容資訊: 英文||
本報告提供全球醫藥品有效成分 (API) 市場相關調查分析，提供產業分析，市場分析，各地區分析，競爭情形，主要企業等相關的系統性資訊。
Active Pharmaceutical Ingredients Market
The Active Pharmaceutical Ingredients Market Size was valued at USD xx million in 2016 and USD xx million in 2017 .
The market forecast for the year 2025 is pegged at USD xx million, with a CAGR of xx% during the period (2018-2025).
Global Active Pharmaceuticals Ingredients Market: Segmentation
The Active Pharmaceutical Ingredients Market Size is segmented based on Type, Nature, Application, and Manufacturing type.
By type, the market is divided into Synthetic API and Biotech API.
Biotech APIs include Monoclonal Antibodies, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Recombinant Enzymes, Antibiotics, Statins, and Others.
By Manufacturing type, the market is divided into Captive and Merchant.
Captive API is the largest segment covering a significant part of the global API market with a market share of approximately 61% while the remaining is taken by Merchant API.
By End User, the market is classified into-Patients with chronical diseases, Physicians, Hetero Labs, Pharmaceutical companies, Hospitals, Parents/Relatives, and Others.
Based on Nature into Generic API and Innovator API.
Based on Application as Cardiovascular, Diabetes, Oncology, Orthopaedics, Neurology, NSAIDS, and Others.
This Active Pharmaceutical Ingredients Report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and Company Profiles.
The report profiles various companies including Aurobindo Pharma, Mylan, Teva Active Pharmaceutical Ingredients, Ipca, Hetero Labs, Pharmaceutical companies Aceto Corporation, Arevipharma GmbH, Dr. Reddy's Laboratories, Pfizer, Inc, Novartis International AG, Sanofi, Ranbaxy, and Sun Pharma.
Aurobindo Pharma has the highest Active Pharmaceutical Ingredients Market Share.
Patent expiration of a drug leads to its generic version and the manufacturers bear the cost.
This decreases the overall cost of the ingredient thereby increasing the number of users, which further increases the global market for the parts.
For instance, the patent for Teva's long-acting MS med Copaxone 40 mg, which has a revenue of $3.48 billion in the U.S. expired allowing the manufacturers to use the technology and produce the drug leading to an increase in production from 80% to 85%.
Patent expiries of the branded drugs, increased uptake of biologics, government initiatives for biomedical research are majorly driving the global Active Pharmaceutical Ingredients Market. However, Unfavourable Drug Price Control Policies Across Various Countries is holding back the growth of the market.
The report segments the geographies by region, which include North America, South America, Europe, Asia Pacific, and RoW.
North America dominates the Global Active Pharmaceutical Ingredients Market with a share of approximately 40.1%, followed by Europe with 24%.
Increasing medical requirements, advancement in R&D and innovations in this regions are favoring the growth of the market.
Visualization of Active Pharmaceutical Ingredients Market composition across each indication, regarding type and applications, highlighting the critical commercial assets and players.
Identification of commercial opportunities in Active Pharmaceutical Ingredients by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of market level 4/5 segmentation
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
Product mapping in excel for crucial products of all major market players